Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)
about
Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case RegistryImmunomodulatory drugs and their application to the management of canine immune-mediated disease.Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirinLack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.Analysis of DLA-DQB1 and polymorphisms in CTLA4 in Cocker spaniels affected with immune-mediated haemolytic anaemiaSystematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemiaDemographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia.The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs.Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use.Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research.Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats.Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs.Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.Screening diagnostics to identify triggers in 21 cases of steroid-responsive meningitis-arteritis.Anti-platelet therapy in small animal medicine.Aortic thrombosis in dogs.Urban environment: a risk factor for canine immune-mediated disease?In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia.Seasonality of immune-mediated hemolytic anemia in dogs from southern California.Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia.Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.A Remote Assay for Measuring Canine Platelet Activation and the Inhibitory Effects of Antiplatelet Agents.Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs.Establishment of reference ranges and evaluation of in vitro concentration-dependent platelet inhibition by acetylsalicylic acid for multiple electrode impedance aggregometry in healthy dogs.Effects of omega-3 polyunsaturated fatty acids and aspirin, alone and combined, on canine platelet function.Evaluation of prognostic indicators for canine primary immune-mediated haemolytic anaemia and application of a scoring system for the determination of prognosis.Platelet cyclooxygenase expression in normal dogs.Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia.The use of therapeutic plasma exchange to reduce serum bilirubin in a dog with kernicterus.Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemiaPresumptive Ischemic Brain Infarction in a Dog with Evans’ Syndrome
P2860
Q28602895-75831513-4DE0-4F4E-90F6-DB1B3B78412EQ33393823-0F43DEE9-129E-4AB8-9EC0-EA016573DCE5Q33428734-EC8A184F-A1FF-4E97-8581-AF8A0A3D7366Q33837587-4BECAF0A-8B7C-4522-AE09-BEC98C472104Q33871622-DA49ED71-F50F-424A-A4F9-5B429CB6899DQ36084432-10889458-3649-4A88-8EED-60F46CEA5DCEQ36873665-480B7051-5DB7-44E4-B72B-C03DE05C5959Q37020350-95287BCB-C95D-4577-B7DA-9F151170BF77Q37277075-D64BD2CB-62D5-43E4-A8C5-63E16AC0943AQ37375461-6BAD1759-E87C-4AA4-90AB-AC2728682CC2Q37731739-04C10E0F-4912-400B-BB06-5EF1C845201FQ37949698-1FBFEC6B-8236-4225-A99F-2732A27392A1Q38046968-EDB0DFA4-C541-47B5-A3A0-3B94C7399587Q38070814-91DF25A4-7BA6-4F69-B804-6075BFFB6335Q38077297-93FF2771-0D4E-4224-A4EC-BD6036CF1121Q38192043-E29F6F8D-D248-43F3-B518-94DC257FF648Q38770733-E468A38C-03D0-40FF-B436-BB8D38F6846CQ38990340-0834B9AF-0772-43A9-9EB9-E005623F4FA6Q40498419-7F95CB80-E779-46AA-90BE-E57C5F91006EQ41073222-739DC648-CAE4-410C-85A7-E8B50A5476A5Q41075079-54876F24-7C86-4680-A5A6-E504082AF09BQ42218489-6ADECE77-7EFE-442E-9489-CD282409C370Q42593168-6EE4890A-7BB9-400A-BC68-4EC4E587C502Q43923331-CD7CDA1B-4E50-4B85-BA94-C39950DF8FC1Q44062351-80DC0A96-A03A-440D-B363-7F579CB5308BQ46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359Q48191729-2EDBA2FD-79A8-4548-A29F-D4A1B67CF6C1Q48196707-E32D740C-BE1B-4CAF-881E-2CFFF23BB11EQ48306826-2ECE6849-E5EE-4006-88FF-86E6718C02C2Q50098017-4FCD1362-FDA8-44E5-94ED-CD80E7FDDF95Q50574707-772E3C40-9900-4896-BD2F-ACBFF942EA3FQ51404174-3A18F794-6B79-412D-9448-74F52C4D1495Q51784695-001251ED-CE90-4001-8838-0E31C9725E4DQ53228288-D3F22C02-997C-4A82-8754-E87D85CC82AEQ58860030-3C573C69-12DC-4453-B1E2-8B2DD81656E8Q59039731-820408FF-4AF9-49D3-AC06-35B157E885D5
P2860
Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@ast
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@en
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@nl
type
label
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@ast
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@en
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@nl
prefLabel
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@ast
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@en
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@nl
P2093
P3181
P1476
Evaluation of prognostic facto ...... in dogs: 151 cases (1993-2002)
@en
P2093
Hollis N Erb
John F Randolph
Karen L Warner
Sharon A Center
Stephen C Barr
Tristan K Weinkle
P304
P3181
P356
10.2460/JAVMA.2005.226.1869
P407
P577
2005-06-01T00:00:00Z